{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:35:56Z","timestamp":1791765356790,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41371-020-0342-4","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T16:05:35Z","timestamp":1588608335000},"page":"351-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Urate-lowering therapy exerts protective effects against hypertension development in patients with gout"],"prefix":"10.1038","volume":"35","author":[{"given":"Kuan-Hung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Shun","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Lun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chii-Min","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"342_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1056\/NEJM196609012750902","volume":"275","author":"PJ Cannon","year":"1966","unstructured":"Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. N Engl J Med. 1966;275:457\u201364.","journal-title":"N Engl J Med"},{"key":"342_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63:102\u201310.","journal-title":"Arthritis Care Res"},{"key":"342_CR3","doi-asserted-by":"publisher","first-page":"e114259","DOI":"10.1371\/journal.pone.0114259","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Qin T, Chen J, Li Y, Wang L, Huang H, et al. Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLOS ONE. 2014;9:e114259.","journal-title":"PLOS ONE."},{"key":"342_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/1756-185X.13266","volume":"21","author":"KH Yu","year":"2018","unstructured":"Yu KH, Chen DY, Chen JH, Chen SY, Chen SM, Cheng TT, et al. Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan. Int J Rheum Dis. 2018;21:772\u201387.","journal-title":"Int J Rheum Dis"},{"key":"342_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/1759720X16646703","volume":"8","author":"SE Sattui","year":"2016","unstructured":"Sattui SE, Gaffo AL. Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications. Ther Adv Musculoskelet Dis. 2016;8:145\u201359.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"342_CR6","doi-asserted-by":"publisher","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","volume":"282","author":"M Mazzali","year":"2002","unstructured":"Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Ren Physiol. 2002;282:F991\u2013F997.","journal-title":"Am J Physiol Ren Physiol"},{"key":"342_CR7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/hy1101.092839","volume":"38","author":"M Mazzali","year":"2001","unstructured":"Mazzali M, Hughes J, Kim JG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38:1101\u20136.","journal-title":"Hypertension."},{"key":"342_CR8","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jama.300.8.924","volume":"300","author":"DI Feig","year":"2008","unstructured":"Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008;300:924\u201332.","journal-title":"JAMA."},{"key":"342_CR9","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.112.196980","volume":"60","author":"B Soletsky","year":"2012","unstructured":"Soletsky B, Feig DI. Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension. 2012;60:1148\u201356.","journal-title":"Hypertension."},{"key":"342_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1377\/hlthaff.22.3.61","volume":"22","author":"TM Cheng","year":"2003","unstructured":"Cheng TM. Taiwan\u2019s new national health insurance program: genesis and experience so far. Health Aff. 2003;22:61\u201376.","journal-title":"Health Aff"},{"key":"342_CR11","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","volume":"17","author":"RB D\u2019Agostino Jr","year":"1998","unstructured":"D\u2019Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265\u201381.","journal-title":"Stat Med."},{"key":"342_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0002-8703(72)90331-6","volume":"84","author":"HA Kahn","year":"1972","unstructured":"Kahn HA, Medalie JH, Neufeld HN, Riss E, Goldbourt U. The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J. 1972;84:171\u201382.","journal-title":"Am Heart J"},{"key":"342_CR13","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman MH. Serum uric acid and cardiovascular mortality. the NHANES I epidemiologic follow-up study, 1971\u201392. JAMA. 2000;283:2404\u201310.","journal-title":"JAMA."},{"key":"342_CR14","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811\u201321.","journal-title":"N Engl J Med"},{"key":"342_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1161\/01.HYP.0000085858.66548.59","volume":"42","author":"DI Feig","year":"2003","unstructured":"Feig DI, John RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2003;42:247\u201352.","journal-title":"Hypertension"},{"key":"342_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/01.HYP.0000150783.79172.bb","volume":"45","author":"AB Alper Jr","year":"2005","unstructured":"Alper AB Jr, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL. Childhood uric acid predicts adult blood pressure: the Bogalusa heart study. Hypertension. 2005;45:34\u201338.","journal-title":"Hypertension."},{"key":"342_CR17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/01.HYP.17.6.969","volume":"17","author":"SC Hunt","year":"1991","unstructured":"Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah: a screening analysis. Hypertension. 1991;17:969\u201376.","journal-title":"Hypertension."},{"key":"342_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1751-7176.2012.00701.x","volume":"15","author":"V Agarwal","year":"2013","unstructured":"Agarwal V, Hans N, Messerli FH. Effect of allopurinol on blood pressure: a systematic review and meta-analysis. J Clin Hypertens. 2013;15:435\u201342.","journal-title":"J Clin Hypertens"},{"key":"342_CR19","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295\u2013300.","journal-title":"Proc R Soc Med"},{"key":"342_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/aje\/kws002","volume":"176","author":"E Krishnan","year":"2012","unstructured":"Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol. 2012;176:108\u201316.","journal-title":"Am J Epidemiol"},{"key":"342_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2337\/dc07-1276","volume":"31","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008;31:361\u20132.","journal-title":"Diabetes Care."},{"key":"342_CR22","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/JIM.0000000000000242","volume":"63","author":"M Takir","year":"2015","unstructured":"Takir M, Kostek O, Ozkok A, Elcioglu OC, Bakan A, Erek A, et al. Lowering uric acid with allopurinol improves insulin resistance and systemic inflammation in asymptomatic hyperuricemia. J Investig Med. 2015;63:924\u20139.","journal-title":"J Investig Med"},{"key":"342_CR23","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1093\/rheumatology\/key138","volume":"57","author":"SW Niu","year":"2018","unstructured":"Niu SW, Chang KT, Ta A, Chang YH, Kuo IC, Hung CC, et al. Decreased incidence of diabetes in patients with gout using benzbromarone. Rheumatology. 2018;57:1574\u201382.","journal-title":"Rheumatology"},{"key":"342_CR24","doi-asserted-by":"publisher","first-page":"e0210085","DOI":"10.1371\/journal.pone.0210085","volume":"14","author":"HW Chang","year":"2019","unstructured":"Chang HW, Lin YW, Lin MH, Lan YC, Wang RY. Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus. PLOS ONE. 2019;14:e0210085.","journal-title":"PLOS ONE."},{"key":"342_CR25","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/sj.ki.5000391","volume":"69","author":"T Nakagawa","year":"2006","unstructured":"Nakagawa T, Kang DH, Feig D, Sanchez-Lozada LG, Srinivas TR, Sautin Y, et al. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int. 2006;69:1722\u20135.","journal-title":"Kidney Int."},{"key":"342_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.ajkd.2010.01.019","volume":"56","author":"G Bellomo","year":"2010","unstructured":"Bellomo G, Venanzi S, Verdura C, Saronio P, Esposito A, Timio M. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis. 2010;56:264\u201372.","journal-title":"Am J Kidney Dis"},{"key":"342_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000326848","volume":"33","author":"H Sonoda","year":"2011","unstructured":"Sonoda H, Takase H, Dohi Y, Kimura G. Uric acid levels predict future development of chronic kidney disease. Am J Nephrol. 2011;33:352\u20137.","journal-title":"Am J Nephrol"},{"key":"342_CR28","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11255-007-9253-3","volume":"39","author":"M Kanbay","year":"2007","unstructured":"Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007;39:1227\u201333.","journal-title":"Int Urol Nephrol"},{"key":"342_CR29","doi-asserted-by":"publisher","first-page":"E2283","DOI":"10.3390\/ijms18112283","volume":"18","author":"A Pisano","year":"2017","unstructured":"Pisano A, Cernaro V, Gembillo G, D\u2019Arrigo G, Buemi M, Bolignano D. Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: an updated systematic review and meta-analysis. Int J Mol Sci. 2017;18:E2283.","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41371-020-0342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-020-0342-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-020-0342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:25:04Z","timestamp":1684617904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-020-0342-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["342"],"URL":"https:\/\/doi.org\/10.1038\/s41371-020-0342-4","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"9 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}